A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings
Nyaradzo Mgodi(University of Zimbabwe), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kagisho Baepanye(Infectious Disease Research Institute), Maurine D. Miner(Fred Hutch Cancer Center), Nandisile Luthuli(Infectious Disease Research Institute), Srilatha Edupuganti(Emory University), Myron S. Cohen(University of North Carolina at Chapel Hill), Carissa Karg(Infectious Disease Research Institute), Nidhi Kochar(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Maija Anderson(Fred Hutch Cancer Center), Simbarashe Takuva(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Precious Garnett(Desmond Tutu HIV Foundation), Emily Shava(Botswana Harvard AIDS Institute Partnership), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Margarita M. Gomez Lorenzo(Norwegian Womens Public Health Association), Pamela Mukwekwerere(University of Zimbabwe), Kyle Marshall(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lawrence Corey(Fred Hutch Cancer Center), India Tindale(Infectious Disease Research Institute), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), John R. Mascola(National Institute of Allergy and Infectious Diseases), Erica Lazarus(Norwegian Womens Public Health Association), Julie E. Ledgerwood(Vaccine Research Institute of San Diego), P. Andrew(Family Health International 360), David Burns(Norwegian Womens Public Health Association), Elizabeth Greene(Impact), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 45
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k